Market: NMS |
Currency:
Address:
📈 JEM Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for JEM
No earnings history available for this symbol.
📰 Related News & Research
-
AnaptysBio to Spin Off Biopharma Unit as First Tracks Biotherapeutics, Reports Strong 2025 Financial Results and Jemperli Royalty Growth
March 4, 2026
AnaptysBio Announces Biopharma Spin-Off and Strong 2025 Fina...
-
Day One Biopharmaceuticals 2026 Outlook: OJEMDA Growth, Pipeline Updates & Financial Highlights
March 2, 2026
Day One Biopharmaceuticals Reports Strong 2025 Results, Pipe...
-
Lendlease REIT Completes S$462 Million Divestment of Jem Office Component and Plans Debt Reduction
November 12, 2025
Detailed Investor Update: Lendlease Global Commercial REIT C...
-
Lendlease Global Commercial REIT Q1 FY2026 Update: Jem Office Divestment, Strong Retail Performance & Sustainability Achievements 1
October 31, 2025
Lendlease REIT’s Strategic Jem Office Divestment and Strong ...
-
Lendlease Global Commercial REIT (LREIT) 2025 Analysis: Jem Office Sale, Dividend Outlook & Growth Opportunities
August 8, 2025
CGS International August 7, 2025 Lendlease Global Commercial...
-
Lendlease Global Commercial REIT Reports 1.8% DPU Growth, Divests Jem Office for S$462M, Strengthens Capital Structure, and Achieves Positive Retail Rental Reversion in FY2025 13
August 4, 2025
Lendlease Global Commercial REIT FY2025 Financial Analysis ...
🔍 View more Reports
